Meanwhile, the digital health industry was squarely focused on managing the impact of existing drugs, which have placed enormous pressure on health care spending
Dosage typically ranges from 200400mcg per administration
By occupying GLP-1 receptors in the brain, the medication promotes insulin release, slows gastric emptying, reduces glucagon secretion from the liver, and affects the hunger control centre (lateral hypothalamus) of the brain to suppress appetite
Semaglutida (Wegovy, Rybelsus) Muy frecuentes (1 de cada 10 personas): nuseas, diarrea o estrimiento, fatiga, hipoglucemia expresada como sudor fro, piel fra y plida, dolor de cabeza, palpitaciones, cambios en la visin, somnolencia o sensacin de debilidad, nerviosismo, ansiedad o confusin, dificultad de concentracin y temblores